105 related articles for article (PubMed ID: 38747920)
1. Drug Analysis of Voriconazole Combined with Granulocyte Colony Stimulating Factor.
Zhang X; Li R; Wang H; Li H; Wu Y
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747920
[TBL] [Abstract][Full Text] [Related]
2. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.
Bacigalupo A; Van Lint MT; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Valeriani A; Piaggio G; Pitto A; Benvenuto F; Figari O; De Stefano G; Caimo A; Sessarego M
Blood; 1996 Jul; 88(1):353-7. PubMed ID: 8704195
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
[TBL] [Abstract][Full Text] [Related]
4. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Purimetla N; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Apr; 42(4):907-10. PubMed ID: 9559806
[TBL] [Abstract][Full Text] [Related]
5. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Chauhan S; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2299-303. PubMed ID: 9736553
[TBL] [Abstract][Full Text] [Related]
6. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
[TBL] [Abstract][Full Text] [Related]
7. Detection of the granulocyte colony-stimulating factor receptor using biotinylated granulocyte colony-stimulating factor: presence of granulocyte colony-stimulating factor receptor on CD34-positive hematopoietic progenitor cells.
Shimoda K; Okamura S; Harada N; Niho Y
Res Exp Med (Berl); 1992; 192(4):245-55. PubMed ID: 1384092
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice.
Samalidou M; Bougiouklis D; Vyzantiadis TA; Meletiadis J; Monokrousos N; Siotou E; Sivropoulou A; Anagnostopoulos A; Sotiropoulos D
Exp Biol Med (Maywood); 2015 Dec; 240(12):1728-34. PubMed ID: 26080459
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
Weisdorf DJ; Verfaillie CM; Davies SM; Filipovich AH; Wagner JE; Miller JS; Burroughs J; Ramsay NK; Kersey JH; McGlave PB
Blood; 1995 Jun; 85(12):3452-6. PubMed ID: 7540062
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
12. Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?
Ener RA; Meglathery SB; Cuhaci B; Topolsky D; Styler MJ; Crilley P; Brodsky I; Kahn SB; King RS
Am J Clin Oncol; 2001 Feb; 24(1):19-25. PubMed ID: 11232944
[TBL] [Abstract][Full Text] [Related]
13. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
Ji S; Chen H; Wang H; Yan H; Pan S
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
[TBL] [Abstract][Full Text] [Related]
14. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.
Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E
Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
[TBL] [Abstract][Full Text] [Related]
17. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
Raina V; Sharma A; Kumar R; Bhargava M
Cancer; 1996 Mar; 77(6):1073-8. PubMed ID: 8635126
[TBL] [Abstract][Full Text] [Related]
18. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
[TBL] [Abstract][Full Text] [Related]
19. Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation.
Fattorossi A; Battaglia A; Pierelli L; Malinconico P; Andreocci L; Perillo A; Ferrandina G; Martelli O; Rughetti A; Nuti M; Cortesi E; Scambia G
Cancer Immunol Immunother; 2001 Feb; 49(12):641-8. PubMed ID: 11258790
[TBL] [Abstract][Full Text] [Related]
20. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
